Please keep checking this site for possible updates.

Video: “Sexual Health and Prostate Cancer”

by jroth on January 16, 2017

November 2016 Awareness Night Sexual Health and Prostate Cancer Dr. Andrew G. Matthew, PhD., C.Psych Assistant Professor, Department of Surgery Assistant Professor, Department of Psychiatry Faculty of Medicine, University of Toronto Senior staff Psychologist, Member of the Department of Psychosocial Oncology and Palliative Care Co-Lead, Genito-Urinary Survivorship Program at the Princess Margaret Cancer Centre CLICK […]

{ 0 comments }

From ZEROHour Newsletter: January 2017 The newly released “2017 Cancer Facts and Figures” report shows the negative impact of the USPSTF recommendation against the PSA test. Read the Newsletter.

{ 0 comments }

Can pomegranates really add years to your life – and fight cancer?

January 2, 2017

In a small study in 2006, University of California researchers found that drinking a daily 227ml glass of pomegranate juice significantly slowed the progress of prostate cancer — it’s thought urolithins block cancer cell growth. Now a U.S. trial involving 30 patients is looking at whether supplements containing the fruit’s extract can prevent prostate cancer […]

Read the article or watch the video →

A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population

January 2, 2017

A pilot study at the Sunnybrook Health Sciences Centre determined the feasibility of using multiparametric prostate magnetic resonance imaging as the primary screening test for prostate cancer. Initial results showed that prostate magnetic resonance imaging was better to predict prostate cancer than prostate specific antigen in an unselected sample of the general population. Read the […]

Read the article or watch the video →

Predicting if your surgery for prostate cancer will fail

January 2, 2017

Many men who are told their surgery for prostate cancer has been a success later discover that this is not the case. The level of a protein in their blood, called prostate specific antigen, PSA, begins to rise signalling they still have prostate cells in their body even though they were told the entire prostate […]

Read the article or watch the video →

Salmonella could shrink prostate cancer cells

January 2, 2017

Scientists at Swansea University say they have made a breakthrough which could revolutionise prostate cancer treatment. Researchers at the university’s School of Medicine have developed a way of shrinking cancer cells using a harmless strain of salmonella bacteria. Read the article here.

Read the article or watch the video →

New prostate cancer test strives to slash biopsies

January 2, 2017

Because PSA is secreted both by normal cells and cancer cells, its levels could be high for other reasons and not necessarily cancer: age, an inflammation of the prostate gland, or even a bicycle ride. But most often when doctors receive a high reading, they send their patients to do a biopsy, just to be […]

Read the article or watch the video →

Prostate Cancer: New Directions With Active Surveillance

January 2, 2017

Howard Wolinsky, a journalist based in the Chicago area, was diagnosed with early prostate cancer in 2010. After over 5 years of active surveillance, he describes his continuing quest to make the best — and most informed — decision about his care. Read the article here.

Read the article or watch the video →

Woman to Watch: Dr. Juanita Crook

January 2, 2017

Dr. Juanita Crook, formerly with Princess Margaret Hospital, is now a professor of radiation oncology at UBC and an oncologist with the B.C. Cancer Agency. She specializes in brachytherapy. Read the article here.

Read the article or watch the video →

Prostate Imaging Reporting and Data System score of four or more: active surveillance no more

January 2, 2017

The introduction of multiparametric MRI (mpMRI) has improved the diagnosis and risk stratification of intermediate and high-risk prostate cancer. In addition to diagnosis, mpMRI has increasingly become a useful tool for monitoring the prostate cancer risk of patients on active surveillance (AS) programmes. Long-term data indicates that there is no oncological benefit for AS programmes […]

Read the article or watch the video →